A randomized clinical trial to evaluate home-based assessment of people over 75 years old.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
05 2019
Historique:
received: 03 08 2018
revised: 09 01 2019
accepted: 09 01 2019
pubmed: 16 3 2019
medline: 27 5 2020
entrez: 16 3 2019
Statut: ppublish

Résumé

There is an unmet need for effective methods for conducting dementia prevention trials. Home-based assessment study compared feasibility and efficiency, ability to capture change over time using in-home instruments, and ability to predict cognitive conversion using predefined triggers in a randomized clinical trial in (1) mail-in questionnaire/live telephone interviews, (2) automated telephone/interactive voice recognition, and (3) internet-based computer Kiosk technologies. Primary endpoint was defined as cognitive conversion. Analysis followed a modified intent-to-treat principle. Dropout rates were low and similar across technologies but participants in Kiosk were more likely to dropout earlier. Staff resources needed were higher in Kiosk. In-home instruments distinguished conversion and stable groups. Cognitively stable group showed improvement in cognitive measures. Triggering was associated with higher likelihood of conversion but statistically significant only in mail-in questionnaire/live telephone interviews. Relatively low efficiency of internet-based assessment compared with testing by live-assessors has implications for internet-based recruitment and assessment efforts currently proposed for diverse populations.

Identifiants

pubmed: 30872114
pii: S1552-5260(19)30028-7
doi: 10.1016/j.jalz.2019.01.007
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

615-624

Subventions

Organisme : NIA NIH HHS
ID : R01 AG024059
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG043362
Pays : United States
Organisme : NIA NIH HHS
ID : U2C AG054397
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG010483
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005142
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Auteurs

Mary Sano (M)

Department of Psychiatry, Alzheimer Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA; James J Peters VAMC, Bronx, NY, USA. Electronic address: mary.sano@mssm.edu.

Carolyn W Zhu (CW)

Department of Psychiatry, Alzheimer Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA; James J Peters VAMC, Bronx, NY, USA; Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Jeffrey Kaye (J)

Department of Neurology and Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.

James C Mundt (JC)

Wisconsin Department of Health Services, Division of Care and Treatment Services, Mauston, WI, USA.

Tamara L Hayes (TL)

Oregon Center for Aging and Technology, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.

Steven Ferris (S)

Center for Cognitive Neurology, New York University Langone Medical Center, New York, NY, USA.

Ronald G Thomas (RG)

Department of Neurosciences, San Diego, CA, USA; Department of Family and Preventive Medicine, University of California, San Diego, CA, USA.

Chung-Kai Sun (CK)

Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, San Diego, CA, USA.

Yanxin Jiang (Y)

Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, San Diego, CA, USA.

Michael C Donohue (MC)

Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, San Diego, CA, USA.

Lon S Schneider (LS)

Department of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Susan Egelko (S)

Department of Psychiatry, Alzheimer Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Paul S Aisen (PS)

Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, San Diego, CA, USA.

Howard H Feldman (HH)

Department of Neurosciences, University of California, San Diego, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH